These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 168807)

  • 21. Polymyxin B-induced cocarde growth phenomenon of Serratia marcescens due to cationic detergent-like activity of polymyxin B.
    Traub WH
    Chemotherapy; 1982; 28(5):363-8. PubMed ID: 6291867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
    Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D
    Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of induction of group A bacteriocins of Serratia marcescens by rifampin.
    Traub WH
    Experientia; 1972 Aug; 28(8):986-8. PubMed ID: 4561798
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of saline on the releasability of alkaline phosphatase from cells of Serratia marcescens.
    Kranz DM; Tsang JC
    Microbios; 1976; 15(61-62):165-75. PubMed ID: 189160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The polymyxin derivative NAB739 is synergistic with several antibiotics against polymyxin-resistant strains of Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii.
    Tyrrell JM; Aboklaish AF; Walsh TR; Vaara T; Vaara M
    Peptides; 2019 Feb; 112():149-153. PubMed ID: 30586602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.
    Markowitz SM; Sibilla DJ
    Antimicrob Agents Chemother; 1980 Nov; 18(5):651-5. PubMed ID: 7004344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paenipeptin Analogues Potentiate Clarithromycin and Rifampin against
    Moon SH; Kaufmann Y; Huang E
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic susceptibilities of Serratia marcescens and Enterobacter liquefaciens.
    Greenup P; Blazevic DJ
    Appl Microbiol; 1971 Sep; 22(3):309-14. PubMed ID: 4330312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulfamethoxazole-trimethoprim-polymyxin therapy of serious multiply drug-resistant Serratia infections.
    Thomas FE; Leonard JM; Alford RH
    Antimicrob Agents Chemother; 1976 Feb; 9(2):201-7. PubMed ID: 178273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of polymyxin B on prodigiosin biosynthesis in Serratia marcescens.
    Tsang JC; Sheung X
    J Antibiot (Tokyo); 1980 Apr; 33(4):455-7. PubMed ID: 6251020
    [No Abstract]   [Full Text] [Related]  

  • 31. Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.
    Wilfert JN; Barrett FF; Ewing WH; Finland M; Kass EH
    Appl Microbiol; 1970 Feb; 19(2):345-52. PubMed ID: 4314379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of clavulanic acid on the in vitro synergism between carbenicillin and gentamicin against Serratia marcescens.
    Sirisanthana T; Lerner SA
    Antimicrob Agents Chemother; 1979 Apr; 15(4):630-2. PubMed ID: 380465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic susceptibility of Serratia marcescens and Serratia liquefaciens.
    Traub WH
    Chemotherapy; 2000; 46(5):315-21. PubMed ID: 10965096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro synergistic effects of fisetin and norfloxacin against aquatic isolates of Serratia marcescens.
    Dong J; Ruan J; Xu N; Yang Y; Ai X
    FEMS Microbiol Lett; 2016 Jan; 363(1):fnv220. PubMed ID: 26567906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of different antibiotic actions combined with rifampicin. In vitro synergism against Pseudomonas and Proteus.
    Urena MT; Barasoain I; Espinosa M; Garcia E; Portoles A
    Chemotherapy; 1975; 21(2):82-9. PubMed ID: 169107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidences for complex formation between polymyxin B and lipopolysaccharides from Serratia marcescens.
    Tsang JC; Weber DA; Brown DA
    J Antibiot (Tokyo); 1976 Jul; 29(7):735-42. PubMed ID: 182663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of alaphosphin (Ro 03-7008) against Serratia marcescens.
    Traub WH
    Chemotherapy; 1980; 26(2):103-10. PubMed ID: 6988181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraphagocytic bactericidal activity of ofloxacin compared with that of aztreonam and ceftriaxone against Serratia marcescens.
    Traub WH; Spohr M; Bauer D
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Feb; 261(1):85-94. PubMed ID: 3518296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergism of aminoglycosides and carbenicillin against resistant strains of Serratia marcescens.
    Lin MY; Tuazon CU; Sheagren JN
    J Antimicrob Chemother; 1979 Jan; 5(1):37-44. PubMed ID: 368005
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.
    Yoon J; Urban C; Terzian C; Mariano N; Rahal JJ
    Antimicrob Agents Chemother; 2004 Mar; 48(3):753-7. PubMed ID: 14982760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.